Imported malaria management in France: Experience report of uncomplicated falciparum malaria treatment in adults with oral atovaquone-proguanil;Analyse rétrospective de 107 cas de paludisme d'importation chez l'adulte: Intérêt de l'association orale atovaquone-proguanil dans le traitement de l'accès simple à Plasmodium falciparum

Presse Medicale

Volumn 35, Issue 4 I, 2006, Pages 571-577

  Vatan, Rémy ^a   Pistone, Thierry ^a   Millet, Pascal ^b   Etienne, Gabriel ^a   Mercié, Patrick ^a   Longy Boursier, Maïté ^a   Malvy, Denis ^a,b  

^a Service de Médecine Interne et des Maladies Tropicales   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; ANTIMALARIAL AGENT; PROGUANIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EOSINOPHILIA; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MEDICAL RECORD; MOSQUITO; ONSET AGE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TRAVEL; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; EOSINOPHIL; FRANCE; HEALTH STATUS; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIMALARIALS; CHLOROGUANIDE; DIAGNOSIS, DIFFERENTIAL; DRUG COMBINATIONS; EOSINOPHILS; FEMALE; FEVER; FRANCE; HEALTH STATUS; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; THROMBOCYTOPENIA; TRAVEL;

EID: 33646942450     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74642-5     Document Type: Article

References (17)

1. Caumes E, Belanger F, Brucker G, Danis M, Gentilini M. Pathologie observée au retour de voyages en dehors de l'Europe. 109 observations. Presse Med. 1991; 20: 1483-6.
2. O'Brien D, Tobin S, Brown GV, Torresi J. Fever in returned travelers: review of hospital admissions for a 3-years period. Clin Infect Dis. 2001; 33: 603-9.
3. Caractéristigues épidémiologigues du paludisme d'importation en France (Données métropolitaines 2000). Centre National de Référence pour les Maladies d'Importation 2002.
4. D'Acremont V, Landry P, Mueller I, Pécoud A, Genton B. Clinical and laboratory predictors of imported malaria in an outpatient setting: an aid to medical decision making in returning travelers with fever. Am J Trop Med Hyg. 2002; 66: 481-6.
5. Badiaga S, Barrau K, Parola P, Brouqui P, Delmont J. Contribution of nonspecific laboratory test to the diagnosis of malaria in febrile travelers returning from endemic areas: value of hypocholesterolemia. J Trav Med. 2002; 9: 117-21.
6. Casalino E, Le Bras J, Chaussin F, Fichelle A, Bouvet E. Predictive factors of malaria in travelers to areas where malaria is endemic. Arch Intern Med. 2002; 162: 1625-30.
7. Malvy D, Djossou F, Thiébault R, Le Bras M. Plasmodies-Malaria: formes cliniques, diagnostic. Encycl Med Chir Maladies Infectieuses. 2000; 8-507-A-20.
8. Raglio A, Parea M, Lorenzi N, Avogadri M, Grigis A, Goglio A. Ten-years experience with imported malaria in Bergamo, Italy. J Travel Med. 1994; 1: 152-5.
9. Ralaimazava P, Bouchaud O, Godineau N, Hamane S, Keundjian A, Durand R et al. Le paludisme d'importation en 2000 dans deux hôpitaux du nord de la région parisenne. Bull Soc Pathol Exot. 2003; 96: 119-22.
10. Recommandations sanitaires pour les voyageurs 2002. BEH. 2002; 24: 111-7.
11. Rendi-Wagner P, Noedl H, Wernsdorfer WH, Wiedermann G, Mikolasek A, Kollaritsch H. Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. Acta Trop. 2002; 81: 167-73.
12. van Riemsdijk MM, Sturkenboom MCJM, Ditters JM, Ligthelm RJ, Overbosch D, Stricker BH. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events. Clin Pharmacol Ther. 2002; 72: 294-301.
13. Overbosch D, Schiltuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD et al. AP versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis. 2001; 33: 1015-21.
14. Hogh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Gunther M et al. AP versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double blind study. Lancet. 2000; 356: 1888-94.
15. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg. 1996; 54: 62-6.
16. Bouchaud O, Monlun E, Muanza K, Fontanet A, Scott T, Goetschel A et al. Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg. 2000; 63: 274-9.
17. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol. 2002; 18: 458-64.